Related Experiment Video
Updated: Mar 30, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Activation of chaperone-mediated autophagy as a potential anticancer therapy
Lorena Galan-Acosta1, Hongguang Xia2, Junying Yuan2
1a Division of Toxicology; Institute of Environmental Medicine; Karolinska Institutet ; Stockholm , Sweden.
Abstract:
Chaperone-mediated autophagy (CMA), a subtype of autophagy, delivers select proteins into the lysosome for degradation. Defects in CMA activity have previously been linked with neurodegenerative diseases due to the accumulation of misfolded proteins, but the role of CMA in cancer is currently not well defined. In a recent study, we provide a novel mechanism by which excessive activation of CMA can be exploited as a method to eliminate cancer cells by inducing metabolic catastrophe and delineate a novel strategy to promote the degradation of HK2 (hexokinase 2) in cancer cells.
Insights
Excessive activation of chaperone-mediated autophagy (CMA) eliminates cancer cells via metabolic catastrophe. This study reveals a novel strategy to degrade hexokinase 2 (HK2) in cancer cells, offering new therapeutic avenues.
Area of Science:
- Molecular Biology
- Cellular Biology
- Cancer Research
Background:
- Chaperone-mediated autophagy (CMA) is a lysosomal degradation pathway for specific proteins.
- CMA defects are linked to neurodegenerative diseases due to protein aggregation.
- The role of CMA in cancer remains poorly understood.
Purpose of the Study:
- To investigate the role of CMA in cancer.
- To identify a novel mechanism for cancer cell elimination via CMA.
- To develop a strategy for targeting hexokinase 2 (HK2) degradation in cancer.
Main Methods:
- Investigated CMA activity in cancer cells.
- Explored the induction of metabolic catastrophe through excessive CMA activation.
- Developed and tested a strategy to promote HK2 degradation via CMA.
Main Results:
- Excessive CMA activation leads to cancer cell death through metabolic catastrophe.
- A novel strategy effectively promotes the degradation of HK2 in cancer cells.
- This approach offers a new perspective on CMA's role in oncology.
Conclusions:
- Excessive CMA activation is a viable strategy for cancer cell elimination.
- Targeting HK2 degradation through CMA presents a promising therapeutic approach for cancer treatment.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
09:59Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression